Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
Related Posts
Ethereum Price Warning – Bulls Losing Grip as Downside Risks Build
Ethereum price started a fresh recovery wave above the $4,450 zone but failed. ETH is still struggling and might slide…
Investors Pile In After Bitcoin’s Decline — Here’s What It Could Mean
Following the flash crash of last week, the Bitcoin price has once again sunk to similar depths, albeit in a…
No New Bitcoin Buys: Strategy Takes A Breather After 3 Consecutive Months
Strategy (previously MicroStrategy), the Bitcoin proxy firm co-founded by Bitcoin bull Michael Saylor, has made headlines once again on Monday,…